Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Access state of the art technologies to facilitate immunology research

Whether you need to generate a tool for your immunology project, or develop a therapy to assess for translational potential, the groups within this Platform have the required expertise

Cellular screening facility

Led by Daniel Ebner at the TDI, the cellular screening facility use multiple screening techniques to identify novel targets for potential therapeutic development. This includes cell-based arrayed small compound screens and CRISPR/Cas9 genome-wide screens. Please contact Daniel Ebner for advice on how this facility can help your immunology project.

Monoclonal antibody facility

Led by Alison Banham, head of NDCLS, the monoclonal antibody facility has significant experience in the development, validation and characterisation of monoclonal antibodies. Please contact Amanda Anderson, the facility manager, for more information.